WHWK Analyst Ratings
Whitehawk Therapeutics Inc (WHWK) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $169.3M, listed on NASDAQ, employing roughly 32 people, carrying a beta of 0.81 to the broader market. Whitehawk Therapeutics, Inc. Led by David J. Lennon, public since 2017-08-01.
Analyst Ratings
In the October 2026 monthly count, 9 analysts rated WHWK: 1 Strong Buy, 5 Buy, 3 Hold, 0 Sell and 0 Strong Sell.
Twelve months earlier, in October 2025: 3 analysts, 0 Strong Buy, 0 Buy, 3 Hold, 0 Sell and 0 Strong Sell.
Price Targets
- Average Target
- $8.33
- Median Target
- $9.00
- High
- $9.00
- Low
- $7.00
- Targets Published, Last 12 Months
- 4
Recent Price Targets
The 4 most recent of at least 4 price targets published in the last 12 months.
| Date | Firm | Analyst | Target | Price When Posted |
|---|---|---|---|---|
| Sep 30, 2026 | Stifel Nicolaus | Not named | $9.00 | $3.76 |
| Jul 13, 2026 | Leerink Partners | Not named | $9.00 | $3.97 |
| May 8, 2026 | Oppenheimer | Jeff Jones | $7.00 | $3.96 |
| Feb 5, 2026 | Oppenheimer | Not named | $6.00 | $2.90 |
Quantitative Rating
WHWK carries a model grade of C- (overall score 1 of 5), computed from six valuation and financial measures (discounted cash flow, return on equity, return on assets, debt to equity, price to earnings and price to book), each scored 1 to 5. It is not an analyst rating.
How to Read WHWK Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked WHWK analyst ratings questions
- What is the WHWK consensus price target?
- As of the latest aggregator update, Whitehawk Therapeutics Inc (WHWK) carries a consensus 12-month price target of $8.33. Target ranges run from a low of $7.00 to a high of $9.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on WHWK?
- In the October 2026 monthly count, 9 analysts rated WHWK, and the distribution tilts to the Buy side: 1 Strong Buy, 5 Buy, 3 Hold, 0 Sell and 0 Strong Sell. Rating consensus moves slowly relative to price; it reflects sell-side conviction over a 12-month horizon rather than near-term momentum.
- What recent ratings actions has WHWK seen?
- Recent ratings actions for WHWK are not currently in the snapshot.
- How do analyst targets affect WHWK options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.